Skip to main content

Research Repository

Advanced Search

Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches

Claire, Ravinder; Coleman, Tim; Leonardi?Bee, Jo; Berlin, Ivan

Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches Thumbnail


Authors

Ravinder Claire

TIM COLEMAN tim.coleman@nottingham.ac.uk
Professor of Primary Care

JO LEONARDI-BEE jo.leonardi-bee@nottingham.ac.uk
Professor of Evidence Synthesis

Ivan Berlin



Abstract

Background and Aims: Due to concerns about increased exposure to nicotine, pregnant women using nicotine replacement therapy (NRT) to stop smoking are usually advised to stop using NRT if they relapse to smoking. This study investigated whether this is justified. We compared changes in saliva cotinine from baseline to 2 weeks post-target quit date pregnant smokers who relapsed to smoking and continued to use their patches having been assigned to use nicotine patches or placebo.

Design and Setting: Controlled pre–post design stratified by intervention condition from the ‘Study of Nicotine Patch in Pregnancy’, a randomized, placebo-controlled trial.

Participants: A sample of 268 pregnant women, assigned placebo (n = 122) or nicotine (n = 146) patches, who returned for further supplies of patches and who reported any smoking in the week prior to a visit at 2 weeks after their target quit date.

Measurements: Saliva cotinine concentrations were measured at baseline and 2 weeks after participants’ target quit dates. Any smoking in the previous week was assessed by self-report, validated by expired air carbon monoxide (CO).

Findings: There was no change in saliva cotinine concentrations between baseline and 2 weeks post-target quit date in saliva cotinine concentration in the nicotine patch group [ratio of geometric means = 0.94, 95% confidence interval (CI) = 0.83 to 1.07; P = 0.37, Bayes factor = 0.15]. However, there was a reduction in reported number of cigarettes smoked/day (mean difference 6, 95% CIs 7 to 5, P less than 0.001) and in CO concentrations (mean difference 3.0 parts per million, 95% CIs 4.2 to 1.9, P less than 0.001). These changes were not significantly different from changes in the placebo group except for cigarette consumption, which reduced more in the nicotine group (P = 0.046).

Conclusions: In women trying to stop smoking with the aid of a nicotine patch but having smoked at 2 weeks post-target quit, their nicotine concentration did not change from baseline, but they reported smoking fewer cigarettes and had lower carbon monoxide concentrations.

Citation

Claire, R., Coleman, T., Leonardi‐Bee, J., & Berlin, I. (2019). Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches. Addiction, 114(9), 1651-1658. https://doi.org/10.1111/add.14662

Journal Article Type Article
Acceptance Date May 14, 2019
Online Publication Date May 20, 2019
Publication Date Sep 1, 2019
Deposit Date Jun 24, 2019
Publicly Available Date Jul 4, 2019
Journal Addiction
Print ISSN 0965-2140
Electronic ISSN 1360-0443
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 114
Issue 9
Pages 1651-1658
DOI https://doi.org/10.1111/add.14662
Public URL https://nottingham-repository.worktribe.com/output/2223848
Publisher URL https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14662
Contract Date Jun 24, 2019

Files





You might also like



Downloadable Citations